TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women.

doi:10.1007/s12032-014-0286-z

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women.

Medical oncology (Northwood, London, England) - 1 Nov 2014

Zając Agnieszka, Smolarz Beata, Stachowiak Grzegorz, Wilczyński Jacek R

Abstract excerpt

The aim of the study was to determine an association of TP53 codon 72 (Arg72Pro, G>C transversion, rs1042522) and MDM2 SNP309 (T>G change, rs2279744) polymorphisms in endometrial cancer (EC) of postmenopausal women, regarding grading and staging of EC. In the study, endometrial samples from 202 p...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Endometrial Neoplasms

Share to Neoplasm Staging

Share to Postmenopause

Share to Proto-Oncogene Proteins c-mdm2

Share to Risk Factors

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 25316267
DOI: 10.1007/s12032-014-0286-z
PMCID: PMC4197345

Genes

MDM2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25316267-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women.PMID 25316267Read ↗

Polymorphisms of codon 72 of the TP53 gene in endometrial carcinoma of postmenopausal women.Semantic proximity Read ↗

Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer.Semantic proximity Read ↗

MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis.Semantic proximity Read ↗

Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer.Semantic proximity Read ↗

Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer.Semantic proximity Read ↗

Association between MDM2 SNP309 polymorphism and endometrial cancer risk in Polish women.Semantic proximity Read ↗

Meta-analysis of an association of codon 72 polymorphisms of the p53 gene with increased endometrial cancer risk.Semantic proximity Read ↗

TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study.Semantic proximity Read ↗

The association between codon72 polymorphism of p53 gene and the risk of endometrial cancer: an updating meta-analysis.Semantic proximity Read ↗

Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma.Semantic proximity Read ↗

MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.Semantic proximity Read ↗

Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.